Grant Awards

GrantAwards
Lankenau Institute researchers compete for grants nationally and locally from federal and state funding agencies such as the National Institutes of Health (NIH) as well as through private and family foundations. The grants listed below represent some of the funding that has been awarded to our investigators.

Funding Agency

Project

Principal Investigator

Project Period

Grant Award

NIH
IDO2 Targeting for
Pancreatic Cancer Treatment
G. Prendergast 09/11 - 08/12 $401,141
Susan G. Komen
for The Cure

Immune-Based Suppression
of Breast Cancer Metastasis
by Targeting IDO
A. Muller 08/11 - 08/14 $599,774
NIH
IDO Inhibitors for
Combinatorial Cancer Therapy
G. Prendergast 08/11 - 05/16 $1,278,315
NIH
Human Monoclonal Antibodies
that Bind Botulinum Toxins 
S. Dessain 02/11 - 01/15 $1,956,691
NIH


IDO Pathways in Inflammatory
Pathogenesis and Treatment
of Rheumatoid Arthritis

L. Mandik-Nayak 07/10 - 04/15 $1,796,850


NIH


Targeting Nanoparticle DNA
Therapy for Ovarian Cancer


J. Sawicki


2/08 - 12/12


$1,375,567

NIH  

Polyamines and
Epithelial Tumorigenesis

 

S. Gilmour

 

12/06 -7/12

 $1,576,426

Contact Info

Lankenau Institute
for Medical Research

100 East Lancaster Avenue
Wynnewood, PA 19096

484-476-8400 phone
484-476-8533 fax
info@limr.org

Main Line Health